Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

LutrePulse Hypogonadotropic Hypogonadism

ClinicalTrials.gov ID: NCT01976728

Public ClinicalTrials.gov record NCT01976728. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 11:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the ovulation rate in women with primary amenorrhea with hypogonadotropic hypogonadism following pulsatile gonadotropin-releasing hormone (GnRH) treatment using the OmniPod pump versus placebo

Study identification

NCT ID
NCT01976728
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ferring Pharmaceuticals
Industry
Enrollment
39 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 40 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 1, 2014 (Actual)
Primary completion
Feb 23, 2018 (Actual)
Completion
Feb 23, 2018 (Actual)
Last update posted
Mar 3, 2021

2014 – 2018

United States locations

U.S. sites
33
U.S. states
22
U.S. cities
31
Facility City State ZIP Site status
Fertility Treatment Center Tempe Arizona — —
Center for Reproductive Health UCSF San Francisco California — —
University of Colorado School of Medicine Aurora Colorado — —
Reproductive Associates of Delaware Newark Delaware — —
Columbia Fertility Associates Washington D.C. District of Columbia — —
Women's Medical Research Group, LLC Clearwater Florida — —
Center for Reproductive Medicine Orlando Florida — —
Georgia Reproductive Specialists Atlanta Georgia — —
Fertility Centers of Illinois Chicago Illinois — —
Cypress Medical Research Center Wichita Kansas — —
Bluegrass Clinical Research Inc. Louisville Kentucky — —
Maine Medical Center-REI Portland Maine — —
Massachusetts General Hospital Boston Massachusetts — —
Wayne State University Physicians Group Southfield Michigan — —
Weill Cornell Medical College New York New York — —
Carolinas HealthCare System Charlotte North Carolina — —
Lyndhurst Clinical Research Winston-Salem North Carolina — —
Wake Forest University Health Sciences Winston-Salem North Carolina — —
Institute for Reproductive Health Cincinnati Ohio — —
University of Cincinnati Physicians Cincinnati Ohio — —
UH Case Medical Center, MacDonald Clinical Trials Cleveland Ohio — —
Ohio Reproductive Medicine Columbus Ohio — —
University of Oklahoma Health Sciences Center, Abington IVF & Genetics, L.P. Oklahoma City Oklahoma — —
Abington Reproductive Medicine, PC Abington Pennsylvania — —
Main Line Fertility Center Bryn Mawr Pennsylvania — —
Penn State MS Hershey Medical Center, Penn State College of Medicine Hershey Pennsylvania — —
University of Pittsburgh, Magee-Womens Hospital Pittsburgh Pennsylvania — —
Fertility Associates of Memphis PLLC Memphis Tennessee — —
Center for Assisted Reproduction Bedford Texas — —
Houston Fertility Institute Houston Texas — —
Center of Reproductive Medicine Webster Texas — —
Utah Fertility Center Pleasant Grove Utah — —
Jones Institute for Reproductive Medicine Norfolk Virginia — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01976728, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 3, 2021 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01976728 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →